Table 1.
Cohort | Group | N | Treatment | Day of Drug Exposure/Procedure Conducted | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8-14 | 15 | 22-28 | 31-38 | 39-45 | 45 | 50-53 | 83-90 | 90 | 174-180 | 180 | ||||
1 | A | 6 | VEH | OR | SAC | |||||||||
B | 6 | HAL | OR | SAC | ||||||||||
C | 6 | RISP | OR | SAC | ||||||||||
2 | D | 12 | VEH | OR | SAC | |||||||||
E | 6 | HAL | OR | SAC | ||||||||||
F | 6 | RISP | OR | SAC | ||||||||||
3 | G | 12 | VEH | OR | SAC | |||||||||
H | 6 | HAL | OR | SAC | ||||||||||
I | 6 | RISP | OR | SAC | ||||||||||
4 | J | 6 | VEH | WM | WM | OR | WM | Motor | WM | SAC | ||||
K | 6 | HAL | WM | WM | OR | WM | Motor | WM | SAC | |||||
L | 6 | RISP | WM | WM | OR | WM | Motor | WM | SAC | |||||
5 | M | 6 | VEH | WM | WM | WM | Motor | WM | WM | SAC | ||||
N | 6 | HAL | WM | WM | WM | Motor | WM | WM | SAC | |||||
O | 6 | RISP | WM | WM | WM | Motor | WM | WM | SAC |
Grp=Group; Trt=treatment; VEH = vehicle; HAL = haloperidol; RISP = risperidone; OR = object recognition; WM =water maze; SAC= sacrifice; Motor = motor function test (open field, rotor-rod, and grip strength)